| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |